The standpoint of AIDS research and therapy programs

Area of Science:

• Virology
• Immunology
• Public Health

Background:

• Significant advancements in understanding HIV-1 pathogenesis and antiretroviral therapy (ART) efficacy.
• ART prolongs survival for patients with acquired immunodeficiency syndrome (AIDS) by suppressing HIV-1 replication.

Purpose of the Study:

• To address limitations of current HIV-1 treatments, including failure to eradicate the virus and prevent AIDS-related malignancies.
• To explore alternative therapeutic strategies for HIV-1/AIDS treatment and prevention, considering global access and cost barriers.

Main Methods:

• Review of current understanding of HIV-1 pathogenesis.
• Analysis of the efficacy and limitations of existing antiretroviral therapies.
• Evaluation of the incidence and impact of AIDS-related malignancies.
• Assessment of global access and cost challenges for ART.

Main Results:

• Current ART effectively suppresses HIV-1 replication and increases patient survival.
• ART does not eradicate HIV-1, leaving patients susceptible to AIDS-related malignancies (Kaposi's sarcoma, lymphomas, etc.).
• High cost of ART limits global access, particularly in developing countries, hindering effective AIDS intervention.

Conclusions:

• Despite progress, current HIV-1 therapies are insufficient for viral eradication and preventing associated cancers.
• The rising incidence of AIDS-related malignancies necessitates further research.
• Developing cost-effective and accessible alternative treatments is crucial for global AIDS control and prevention efforts.